3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Conditions
Hyperthermia
9
Prostatic Neoplasms
4
Uterine Cervical Neoplasms
3
Ovarian Neoplasms
3
Sarcoma
2
Neoplasms
2
Melanoma
2
Lung Neoplasms
2
Head and Neck Neoplasms
2
Colonic Neoplasms
2
Carcinoma, Hepatocellular
2
Breast Neoplasms
2
Urinary Bladder Neoplasms
1
Salivary Gland Adenoma, Pleomorphic
1
Recurrence
1
Rectal Neoplasms
1
Prehypertension
1
Prediabetic State
1
Polycystic Ovary Syndrome
1
Pelvic Pain
1
Obesity
1
Neoplasms, Radiation-Induced
1
Neoplasm Metastasis
1
Metabolic Syndrome
1
Locally Advanced Rectal Cancer
1
Liver Neoplasms
1
Kidney Neoplasms
1
Cholangiocarcinoma
1
Agnosia
1
Acute Pain
1
Interventions
Metformin
4
Magnetic Resonance Spectroscopy
2
Exercise
2
Ethinyl Estradiol
2
drospirenone and ethinyl estradiol combination
1
drospirenone
1
Walking
1
Sugars
1
Spironolactone
1
Preoperative Exercise
1
Phlebotomy
1
Pancreaticoduodenectomy
1
Inositol
1
Hepatectomy
1
Flutamide
1
Diet, Reducing
1
Diet, Mediterranean
1
Diet, Fat-Restricted
1
Diet Therapy
1
Diet
1
Diathermy
1
Cyproterone Acetate
1
Caloric Restriction
1
Bloodletting
1
Blood Pressure
1
Blood Donation
1
Absorptiometry, Photon
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Metabolic Syndrome
×
Diathermy
×
Clear all
NCT03644524
2018-08-23
CMH
University of Oregon
Phase NA
Completed
20 enrolled